TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Ward, E. AU - Hao, Y. AU - Xu, J. AU - Thun, M. J. PY - 2009 DA - 2009// TI - Cancer statistics, 2009 JO - CA Cancer J Clin VL - 59 UR - https://doi.org/10.3322/caac.20006 DO - 10.3322/caac.20006 ID - Jemal2009 ER - TY - JOUR AU - Paller, C. J. AU - Antonarakis, E. S. PY - 2013 DA - 2013// TI - Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions JO - Clin Adv Hematol Oncol HO VL - 11 ID - Paller2013 ER - TY - JOUR AU - Antonarakis, E. S. AU - Feng, Z. AU - Trock, B. J. AU - Humphreys, E. B. AU - Carducci, M. A. AU - Partin, A. W. PY - 2012 DA - 2012// TI - The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up JO - BJU Int VL - 109 UR - https://doi.org/10.1111/j.1464-410X.2011.10422.x DO - 10.1111/j.1464-410X.2011.10422.x ID - Antonarakis2012 ER - TY - JOUR AU - D’Amico, A. V. AU - Whittington, R. AU - Malkowicz, S. B. AU - Schultz, D. AU - Blank, K. AU - Broderick, G. A. PY - 1998 DA - 1998// TI - Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JO - JAMA VL - 280 UR - https://doi.org/10.1001/jama.280.11.969 DO - 10.1001/jama.280.11.969 ID - D’Amico1998 ER - TY - JOUR AU - Roach, M. AU - Lu, J. AU - Pilepich, M. V. AU - Asbell, S. O. AU - Mohiuddin, M. AU - Terry, R. PY - 2000 DA - 2000// TI - Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials JO - Int J Radiat Oncol Biol Phys VL - 47 UR - https://doi.org/10.1016/S0360-3016(00)00578-2 DO - 10.1016/S0360-3016(00)00578-2 ID - Roach2000 ER - TY - JOUR AU - Roach, M. AU - Weinberg, V. AU - Nash, M. AU - Sandler, H. M. AU - McLaughlin, P. W. AU - Kattan, M. W. PY - 2006 DA - 2006// TI - Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials JO - J Urol VL - 176 ID - Roach2006 ER - TY - JOUR AU - Huang, J. AU - Vicini, F. A. AU - Williams, S. G. AU - Ye, H. AU - McGrath, S. AU - Ghilezan, M. PY - 2012 DA - 2012// TI - Percentage of positive biopsy cores: a better risk stratification model for prostate cancer? JO - Int J Radiat Oncol Biol Phys VL - 83 UR - https://doi.org/10.1016/j.ijrobp.2011.09.043 DO - 10.1016/j.ijrobp.2011.09.043 ID - Huang2012 ER - TY - JOUR AU - Cooperberg, M. R. AU - Pasta, D. J. AU - Elkin, E. P. AU - Litwin, M. S. AU - Latini, D. M. AU - DuChane, J. PY - 2005 DA - 2005// TI - The UCSF Cancer of the prostate risk assessment (CAPRA) score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy JO - J Urol VL - 173 UR - https://doi.org/10.1097/01.ju.0000158155.33890.e7 DO - 10.1097/01.ju.0000158155.33890.e7 ID - Cooperberg2005 ER - TY - STD TI - Kim Y-J, Cho KH, Pyo HR, Lee KH, Moon SH, Kim TH, et al. Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: comparison of treatment outcomes. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 2014. ID - ref9 ER - TY - JOUR AU - Meurs, P. AU - Galvin, R. AU - Fanning, D. M. AU - Fahey, T. PY - 2013 DA - 2013// TI - Prognostic value of the CAPRA clinical prediction rule: a systematic review and meta-analysis JO - BJU Int VL - 111 UR - https://doi.org/10.1111/j.1464-410X.2012.11400.x DO - 10.1111/j.1464-410X.2012.11400.x ID - Meurs2013 ER - TY - STD TI - UCSF-CAPRA Score for Prostate Cancer Risk. MDCalc. https://www.mdcalc.com/ucsf-capra-score-prostate-cancer-risk. Accessed 18 Sep 2018. UR - https://www.mdcalc.com/ucsf-capra-score-prostate-cancer-risk ID - ref11 ER - TY - STD TI - UCSF Department of Urology | Prostate Cancer Risk Assessment and the UCSF-CAPRA Score. https://urology.ucsf.edu/research/cancer/prostate-cancer-risk-assessment-and-the-ucsf-capra-score. Accessed 18 Sep 2018. UR - https://urology.ucsf.edu/research/cancer/prostate-cancer-risk-assessment-and-the-ucsf-capra-score ID - ref12 ER - TY - JOUR AU - Smart, A. PY - 2006 DA - 2006// TI - A multi-dimensional model of clinical utility JO - Int J Qual Health Care VL - 18 UR - https://doi.org/10.1093/intqhc/mzl034 DO - 10.1093/intqhc/mzl034 ID - Smart2006 ER - TY - STD TI - Development Core Team R. R: a language and environment for statistical computing. Vienna, Austria; 2010. http://www.R-project.org/ UR - http://www.R-project.org/ ID - ref14 ER - TY - JOUR AU - Poisot, T. PY - 2011 DA - 2011// TI - The digitize package: extracting numerical data from scatterplots JO - R J VL - 3 ID - Poisot2011 ER - TY - JOUR AU - Parmar, M. K. AU - Torri, V. AU - Stewart, L. PY - 1998 DA - 1998// TI - Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints JO - Stat Med VL - 17 UR - https://doi.org/3.0.CO;2-8 DO - 3.0.CO;2-8 ID - Parmar1998 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Egger, M. AU - Davey Smith, G. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Higgins, J. P. T. AU - Thompson, S. G. PY - 2002 DA - 2002// TI - Quantifying heterogeneity in a meta-analysis JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1186 DO - 10.1002/sim.1186 ID - Higgins2002 ER - TY - JOUR AU - Combescure, C. AU - Foucher, Y. AU - Jackson, D. PY - 2014 DA - 2014// TI - Meta-analysis of single-arm survival studies: a distribution-free approach for estimating summary survival curves with random effects JO - Stat Med VL - 33 UR - https://doi.org/10.1002/sim.6111 DO - 10.1002/sim.6111 ID - Combescure2014 ER - TY - JOUR AU - Combescure, C. AU - Daures, J. P. AU - Foucher, Y. PY - 2016 DA - 2016// TI - A literature-based approach to evaluate the predictive capacity of a marker using time-dependent summary receiver operating characteristics JO - Stat Methods Med Res VL - 25 UR - https://doi.org/10.1177/0962280212464542 DO - 10.1177/0962280212464542 ID - Combescure2016 ER - TY - JOUR AU - Weinstein, M. C. AU - Torrance, G. AU - McGuire, A. PY - 2009 DA - 2009// TI - QALYs: the basics JO - Value Health VL - 12 UR - https://doi.org/10.1111/j.1524-4733.2009.00515.x DO - 10.1111/j.1524-4733.2009.00515.x ID - Weinstein2009 ER - TY - JOUR AU - Foucher, Y. AU - Lorent, M. AU - Tessier, P. AU - Supiot, S. AU - Sébille, V. AU - Dantan, E. PY - 2018 DA - 2018// TI - A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients JO - Health Qual Life Outcomes VL - 16 UR - https://doi.org/10.1186/s12955-018-0870-6 DO - 10.1186/s12955-018-0870-6 ID - Foucher2018 ER - TY - JOUR AU - Dantan, E. AU - Foucher, Y. AU - Lorent, M. AU - Giral, M. AU - Tessier, P. PY - 2018 DA - 2018// TI - Optimal threshold estimator of a prognostic marker by maximizing a time-dependent expected utility function for a patient-centered stratified medicine JO - Stat Methods Med Res VL - 27 UR - https://doi.org/10.1177/0962280216671161 DO - 10.1177/0962280216671161 ID - Dantan2018 ER - TY - JOUR AU - Royston, P. AU - Parmar, M. K. PY - 2013 DA - 2013// TI - Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome JO - BMC Med Res Methodol VL - 13 UR - https://doi.org/10.1186/1471-2288-13-152 DO - 10.1186/1471-2288-13-152 ID - Royston2013 ER - TY - JOUR AU - Bill-Axelson, A. AU - Holmberg, L. AU - Filén, F. AU - Ruutu, M. AU - Garmo, H. AU - Busch, C. PY - 2008 DA - 2008// TI - Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial JO - J Natl Cancer Inst VL - 100 UR - https://doi.org/10.1093/jnci/djn255 DO - 10.1093/jnci/djn255 ID - Bill-Axelson2008 ER - TY - JOUR AU - Bolla, M. AU - Tienhoven, G. AU - Warde, P. AU - Dubois, J. B. AU - Mirimanoff, R. -. O. AU - Storme, G. PY - 2010 DA - 2010// TI - External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(10)70223-0 DO - 10.1016/S1470-2045(10)70223-0 ID - Bolla2010 ER - TY - JOUR AU - Denham, J. W. AU - Joseph, D. AU - Lamb, D. S. AU - Spry, N. A. AU - Duchesne, G. AU - Matthews, J. PY - 2014 DA - 2014// TI - Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial JO - Lancet Oncol. VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70328-6 DO - 10.1016/S1470-2045(14)70328-6 ID - Denham2014 ER - TY - JOUR AU - Horwitz, E. M. AU - Bae, K. AU - Hanks, G. E. AU - Porter, A. AU - Grignon, D. J. AU - Brereton, H. D. PY - 2008 DA - 2008// TI - Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.9021 DO - 10.1200/JCO.2007.14.9021 ID - Horwitz2008 ER - TY - JOUR AU - Koerber, F. AU - Waidelich, R. AU - Stollenwerk, B. AU - Rogowski, W. PY - 2014 DA - 2014// TI - The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer JO - BMC Health Serv Res VL - 14 UR - https://doi.org/10.1186/1472-6963-14-163 DO - 10.1186/1472-6963-14-163 ID - Koerber2014 ER - TY - JOUR AU - Hanmer, J. AU - Vanness, D. AU - Gangnon, R. AU - Palta, M. AU - Fryback, D. G. PY - 2010 DA - 2010// TI - Three methods tested to model SF-6D health utilities for health states involving comorbidity/co-occurring conditions JO - J Clin Epidemiol VL - 63 UR - https://doi.org/10.1016/j.jclinepi.2009.06.013 DO - 10.1016/j.jclinepi.2009.06.013 ID - Hanmer2010 ER - TY - JOUR AU - Ara, R. AU - Brazier, J. PY - 2017 DA - 2017// TI - Estimating health state utility values for comorbidities JO - PharmacoEconomics VL - 35 UR - https://doi.org/10.1007/s40273-017-0551-z DO - 10.1007/s40273-017-0551-z ID - Ara2017 ER - TY - JOUR AU - Loeb, S. AU - Curnyn, C. AU - Walter, D. AU - Fagerlin, A. AU - Siebert, U. AU - Mühlberger, N. PY - 2018 DA - 2018// TI - Health state utilities among contemporary prostate cancer patients on active surveillance JO - Transl Androl Urol VL - 7 UR - https://doi.org/10.21037/tau.2017.03.80 DO - 10.21037/tau.2017.03.80 ID - Loeb2018 ER - TY - JOUR AU - Krahn, M. D. AU - Bremner, K. E. AU - Alibhai, S. M. H. AU - Ni, A. AU - Tomlinson, G. AU - Laporte, A. PY - 2013 DA - 2013// TI - A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada JO - Qual Life Res VL - 22 UR - https://doi.org/10.1007/s11136-013-0401-1 DO - 10.1007/s11136-013-0401-1 ID - Krahn2013 ER - TY - JOUR AU - Jayadevappa, R. AU - Schwartz, J. S. AU - Chhatre, S. AU - Wein, A. J. AU - Bruce Malkowicz, S. PY - 2010 DA - 2010// TI - Association between utility and treatment among patients with prostate cancer JO - Qual Life Res VL - 19 UR - https://doi.org/10.1007/s11136-010-9622-8 DO - 10.1007/s11136-010-9622-8 ID - Jayadevappa2010 ER - TY - STD TI - Avila M, Becerra V, Guedea F, Suárez JF, Fernandez P, Macías V, et al. Estimating preferences for treatments in patients with localized prostate Cancer. Int J Radiat Oncol Biol Phys. 2014. ID - ref36 ER - TY - JOUR AU - Stewart, S. T. AU - Lenert, L. AU - Bhatnagar, V. AU - Kaplan, R. M. PY - 2005 DA - 2005// TI - Utilities for prostate cancer health states in men aged 60 and older JO - Med Care VL - 43 UR - https://doi.org/10.1097/01.mlr.0000156862.33341.45 DO - 10.1097/01.mlr.0000156862.33341.45 ID - Stewart2005 ER - TY - JOUR AU - Shimizu, H. AU - Horimoto, Y. AU - Arakawa, A. AU - Sonoue, H. AU - Kurata, M. AU - Kosaka, T. PY - 2015 DA - 2015// TI - Application of a 70-gene expression profile to Japanese breast Cancer patients JO - Breast Care Basel Switz VL - 10 UR - https://doi.org/10.1159/000376562 DO - 10.1159/000376562 ID - Shimizu2015 ER - TY - JOUR AU - Cooperberg, M. R. AU - Freedland, S. J. AU - Pasta, D. J. AU - Elkin, E. P. AU - Presti, J. C. AU - Amling, C. L. PY - 2006 DA - 2006// TI - Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy JO - Cancer VL - 107 UR - https://doi.org/10.1002/cncr.22262 DO - 10.1002/cncr.22262 ID - Cooperberg2006 ER - TY - JOUR AU - Ishizaki, F. AU - Hoque, M. A. AU - Nishiyama, T. AU - Kawasaki, T. AU - Kasahara, T. AU - Hara, N. PY - 2011 DA - 2011// TI - External validation of the UCSF-CAPRA (University of California, san Francisco, Cancer of the prostate risk assessment) in Japanese patients receiving radical prostatectomy JO - Jpn J Clin Oncol VL - 41 UR - https://doi.org/10.1093/jjco/hyr136 DO - 10.1093/jjco/hyr136 ID - Ishizaki2011 ER - TY - JOUR AU - Loeb, S. AU - Carvalhal, G. F. AU - Kan, D. AU - Desai, A. AU - Catalona, W. J. PY - 2012 DA - 2012// TI - External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy series JO - Urol Oncol VL - 30 UR - https://doi.org/10.1016/j.urolonc.2010.06.007 DO - 10.1016/j.urolonc.2010.06.007 ID - Loeb2012 ER - TY - JOUR AU - May, M. AU - Knoll, N. AU - Siegsmund, M. AU - Fahlenkamp, D. AU - Vogler, H. AU - Hoschke, B. PY - 2007 DA - 2007// TI - Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients JO - J Urol VL - 178 UR - https://doi.org/10.1016/j.juro.2007.07.043 DO - 10.1016/j.juro.2007.07.043 ID - May2007 ER - TY - JOUR AU - Zhao, K. H. AU - Hernandez, D. J. AU - Han, M. AU - Humphreys, E. B. AU - Mangold, L. A. AU - Partin, A. W. PY - 2008 DA - 2008// TI - External validation of University of California, san Francisco, Cancer of the prostate risk assessment score JO - Urology VL - 72 UR - https://doi.org/10.1016/j.urology.2007.11.165 DO - 10.1016/j.urology.2007.11.165 ID - Zhao2008 ER - TY - JOUR AU - Budaus, L. AU - Isbarn, H. AU - Tennstedt, P. AU - Salomon, G. AU - Schlomm, T. AU - Steuber, T. PY - 2012 DA - 2012// TI - Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the prostate risk assessment score: results from 2937 European patients JO - BJU Int VL - 110 UR - https://doi.org/10.1111/j.1464-410X.2012.11147.x DO - 10.1111/j.1464-410X.2012.11147.x ID - Budaus2012 ER - TY - JOUR AU - Seo, W. I. AU - Kang, P. M. AU - Chung, J. I. PY - 2014 DA - 2014// TI - Predictive value of the cancer of the prostate risk assessment score for recurrence-free survival after radical prostatectomy in Korea: a single-surgeon series JO - Korean J Urol VL - 55 UR - https://doi.org/10.4111/kju.2014.55.5.321 DO - 10.4111/kju.2014.55.5.321 ID - Seo2014 ER - TY - JOUR AU - Yoshida, T. PY - 2013 DA - 2013// TI - Editorial comment to Japan Cancer of the prostate risk assessment for combined androgen blockade including bicalutamide: clinical application and validation JO - Int J Urol Off J Jpn Urol Assoc VL - 20 ID - Yoshida2013 ER - TY - JOUR AU - Tamblyn, D. J. AU - Chopra, S. AU - Yu, C. AU - Kattan, M. W. AU - Pinnock, C. AU - Kopsaftis, T. PY - 2011 DA - 2011// TI - Comparative analysis of three risk assessment tools in Australian patients with prostate cancer JO - BJU Int VL - 108 UR - https://doi.org/10.1111/j.1464-410X.2011.10687.x DO - 10.1111/j.1464-410X.2011.10687.x ID - Tamblyn2011 ER - TY - JOUR AU - Lughezzani, G. AU - Lazzeri, M. AU - Larcher, A. AU - Lista, G. AU - Scattoni, V. AU - Cestari, A. PY - 2012 DA - 2012// TI - Development and internal validation of a prostate health index based nomogram for predicting prostate cancer at extended biopsy JO - J Urol VL - 188 UR - https://doi.org/10.1016/j.juro.2012.06.025 DO - 10.1016/j.juro.2012.06.025 ID - Lughezzani2012 ER - TY - JOUR AU - Hutchinson, L. PY - 2014 DA - 2014// TI - Closing the controversies gap in prostate cancer? JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.87 DO - 10.1038/nrclinonc.2014.87 ID - Hutchinson2014 ER - TY - JOUR AU - Chang, A. J. AU - Autio, K. A. AU - Roach, M. AU - Scher, H. I. PY - 2014 DA - 2014// TI - High-risk prostate cancer[mdash]classification and therapy JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.68 DO - 10.1038/nrclinonc.2014.68 ID - Chang2014 ER - TY - JOUR AU - Klotz, L. AU - Emberton, M. PY - 2014 DA - 2014// TI - Management of low risk prostate cancer-active surveillance and focal therapy JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.73 DO - 10.1038/nrclinonc.2014.73 ID - Klotz2014 ER - TY - STD TI - Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, et al. Patient-reported outcomes after monitoring, surgery, or Radiotherapy for Prostate Cancer. N Engl J Med. 2016. ID - ref52 ER - TY - JOUR AU - Hamdy, F. C. AU - Donovan, J. L. AU - Lane, J. A. AU - Mason, M. AU - Metcalfe, C. AU - Holding, P. PY - 2016 DA - 2016// TI - 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate Cancer JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1606220 DO - 10.1056/NEJMoa1606220 ID - Hamdy2016 ER - TY - JOUR AU - Vickers, A. J. AU - Elkin, E. B. PY - 2006 DA - 2006// TI - Decision curve analysis: a novel method for evaluating prediction models JO - Med Decis Mak Int J Soc Med Decis Mak VL - 26 UR - https://doi.org/10.1177/0272989X06295361 DO - 10.1177/0272989X06295361 ID - Vickers2006 ER - TY - JOUR AU - Traeger, A. C. AU - Hübscher, M. AU - McAuley, J. H. PY - 2017 DA - 2017// TI - Understanding the usefulness of prognostic models in clinical decision-making JO - J Physiother VL - 63 UR - https://doi.org/10.1016/j.jphys.2017.01.003 DO - 10.1016/j.jphys.2017.01.003 ID - Traeger2017 ER - TY - JOUR AU - Montgomery, A. A. AU - Fahey, T. PY - 2001 DA - 2001// TI - How do patients’ treatment preferences compare with those of clinicians? JO - Qual Health Care QHC VL - 10 UR - https://doi.org/10.1136/qhc.0100039 DO - 10.1136/qhc.0100039 ID - Montgomery2001 ER - TY - JOUR AU - Tentori, K. AU - Pighin, S. AU - Divan, C. AU - Crupi, V. PY - 2018 DA - 2018// TI - Mind the gap: physicians’ assessment of patients’ importance weights in localized prostate cancer JO - PLoS One VL - 13 UR - https://doi.org/10.1371/journal.pone.0200780 DO - 10.1371/journal.pone.0200780 ID - Tentori2018 ER - TY - JOUR AU - Lyman, G. H. AU - Kuderer, N. M. PY - 2005 DA - 2005// TI - The strengths and limitations of meta-analyses based on aggregate data JO - BMC Med Res Methodol VL - 5 UR - https://doi.org/10.1186/1471-2288-5-14 DO - 10.1186/1471-2288-5-14 ID - Lyman2005 ER - TY - JOUR AU - Cooperberg, M. R. AU - Hilton, J. F. AU - Carroll, P. R. PY - 2011 DA - 2011// TI - The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy JO - Cancer VL - 117 UR - https://doi.org/10.1002/cncr.26169 DO - 10.1002/cncr.26169 ID - Cooperberg2011 ER - TY - JOUR AU - Kattan, M. W. AU - Gerds, T. A. PY - 2018 DA - 2018// TI - The index of prediction accuracy: an intuitive measure useful for evaluating risk prediction models JO - Diagn Progn Res VL - 2 UR - https://doi.org/10.1186/s41512-018-0029-2 DO - 10.1186/s41512-018-0029-2 ID - Kattan2018 ER -